Probo Medical Completes Acquisition of National Ultrasound

Probo Medical (“Probo”), a leading global provider of medical imaging equipment, parts, repair and service, announced the acquisition of National Ultrasound, Inc. (“National”). Terms of the transaction were not disclosed.

National was founded in 2003 in Duluth, GA and has grown to be one of the largest ultrasound marketing and sales organizations in the country. National has been recognized in the Inc. 5000 list of fastest growing companies for seven consecutive years. Their team brings over 250 years of combined experience working with major ultrasound OEM’s. Over recent years, National has established themselves as a premier provider of ultrasound sales and support to veterinary practices across the country.

“National has a deep history for their sales and marketing prowess, selling new and pre-owned ultrasound equipment to private practices across the country,” said Michael Asmer, CEO of Probo. “They have leveraged that position to expand into the veterinary market.  The opportunity to connect this expertise to our world-class ultrasound sales, service, and repair services is tremendously exciting.”

“National has been a business built on relationships: with our employees, customers and OEM partners.  We found the same values in Probo as we were looking for a partner that could support, and even accelerate, our growth.  The depth, breadth and value proposition of Probo’s offering in ultrasound is second to none and we are excited to share that with our customers,” said Joe Williams, CEO of National.

Probo Medical is backed by Avista Capital Partners, a leading New York-based private equity firm with more than 40 growth-oriented healthcare businesses globally.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.